Altis Labs
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $31M
Investors
- 7
About Altis Labs
Based in Ontario, Canada, and founded by Felix Baldauf-Lenschen (CEO) in 2019, Altis Labs, Inc. operates as a biotechnology research company offering AI (artificial intelligence) based computational imaging solutions for precision medicines. In September 2026, Altis Labs, Inc. The company offers a software platform, called Nota, that provides next-generation clinical data ingestion, analysis, and predictive imaging insights for biotechnology research and biopharma companies, enabling the accelerated development of promising therapies The platform leverages medical imaging to enhance patient outcomes and accelerate therapeutic development. Additionally, Altis assists clinicians and scientists in conducting medical imaging research to achieve scientific breakthroughs. With Nota, Altis Labs offers a comprehensive suite of features, including data management, collaboration tools, analysis capabilities, and insights The software streamlines imaging workflows, enhances trial design, improves patient stratification, and facilitates biomarker discovery.
Who invested in Altis Labs
7 investors across 2 rounds
See all investors in Altis Labs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Altis Labs
Who invested in Altis Labs?
Altis Labs has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Altis Labs raised?
Altis Labs has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Altis Labs last raise money?
Altis Labs's most recent round on record is a Series A, in Sep 2026.
What does Altis Labs do?
Based in Ontario, Canada, and founded by Felix Baldauf-Lenschen (CEO) in 2019, Altis Labs, Inc.
Where is Altis Labs headquartered?
Altis Labs is headquartered in Toronto, Canada.
Which VCs invest in companies like Altis Labs?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Altis Labs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Altis Labs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.